2027 ICD-10-CM Diagnosis Code P96.2Withdrawal symptoms from therapeutic use of drugs in newborn

ICD-10-CM Codes›P00–P96›P90-P96›P96

ICD-10-CM P96.2
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

P96.2 is a billable ICD-10-CM diagnosis code for withdrawal symptoms from therapeutic use of drugs in newborn. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 791, 793. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 4 closely related codes. Coders also document this condition as neonatal withdrawal symptom from therapeutic use of drug. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neonatal abstinence syndrome.

For Medicare Advantage risk adjustment, P96.2 maps to CMS-HCC Category 137 (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications) under the V28 model, adding a risk factor of about 0.424 for a community, non-dual, aged beneficiary in payment year 2027.

Code Identity

ICD-10-CM Code
P96.2
Billable Status
Yes — Valid for Submission
Code Describes
Withdrawal symptoms from therapeutic use of drugs in newborn
Short Description
Withdrawal symptoms from therapeutic use of drugs in newborn
Same as the full description in the CMS dataset.
Parent Code
Other conditions originating in the perinatal period

Code Classification

ChapterP00–P96Certain conditions originating in the perinatal period
SectionP90-P96Other disorders originating in the perinatal period
CategoryP96Other conditions originating in the perinatal period
This CodeP96.2Withdrawal symptoms from therapeutic use of drugs in newborn

Medicare Risk Adjustment (HCC)Billing

P96.2 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.

CMS-HCC V28 Category (Payment Model)
HCC 137— Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
Payment HCC · PY 2027 one of 308 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.424
community, non-dual, aged · ranges 0.297–0.502 across segments
Hierarchy
Superseded by HCC 135 and HCC 136
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
Not mapped under V24
this diagnosis newly risk-adjusts under the V28 model
Part D (RxHCC)
Not mapped
P96.2 does not risk-adjust in the RxHCC prescription drug model

Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Neonatal withdrawal symptom from therapeutic use of drug
  • Withdrawal symptom

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to P96.2: its own notes plus those printed at Chapter 16. A note printed at a category, block or chapter applies to every code under it.

Includes

Further defines, or gives examples of, the content of the category.

From Chapter 16 (P00-P96) Certain conditions originating in the perinatal period applies to 463 codes
  • conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From Chapter 16 (P00-P96) Certain conditions originating in the perinatal period applies to 463 codes
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • tetanus neonatorum (A33)

Notes

General instructions on how these codes are used.

From Chapter 16 (P00-P96) Certain conditions originating in the perinatal period applies to 463 codes
  • Codes from this chapter are for use on newborn records only, never on maternal records

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name P96.2, its category, or a range that includes it.

Excludes1 1

These codes carry an Excludes1 note naming P96.2: they are not reported together with it, unless the two conditions are unrelated.

  • P93 Reactions and intoxications due to drugs administered to newborn
    withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)

Code First 1

These codes say to code first a condition named in the note, and P96.2 is one of the conditions named.

  • P04.1 Newborn affected by other maternal medication
    withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR PNL014
Neonatal abstinence syndrome
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Uncommon Infant and Newborn Problems

It can be scary when your baby is sick, especially when it is not an everyday problem like a cold or a fever. You may not know whether the problem is serious or how to treat it. If you have concerns about your baby's health, call your health care provider right away.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert P96.2 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
779.5 NB drug withdrawal syndr
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About P96.2Overview

What is the ICD-10 code for withdrawal symptoms from therapeutic use of drugs in newborn?

The ICD-10-CM code for withdrawal symptoms from therapeutic use of drugs in newborn is P96.2 (sometimes written as P962). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is P96.2 (Other conditions originating in the perinatal period) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report withdrawal symptoms from therapeutic use of drugs in newborn on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does P96.2 group to?

When withdrawal symptoms from therapeutic use of drugs in newborn is the principal diagnosis on an inpatient stay, it groups to MS-DRG 793, 791, with relative weights from 4.1073 to 4.2192 depending on complications. Higher weights mean higher Medicare reimbursement.

Is P96.2 a CC or MCC?

CMS lists P96.2 as a CC (complication or comorbidity) for FY 2027. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 4 closely related codes in its exclusion list.

What is the ICD-9 equivalent of P96.2?

Under the General Equivalence Mappings, withdrawal symptoms from therapeutic use of drugs in newborn converts to ICD-9-CM 779.5 (NB drug withdrawal syndr). The mapping is approximate, so confirm the match fits the documentation.

What HCC is P96.2?

P96.2 (withdrawal symptoms from therapeutic use of drugs in newborn) maps to CMS-HCC Category 137 (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications), commonly written as HCC 137, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It does not map to any RxHCC in the Part D prescription drug model.

Does P96.2 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, P96.2 adds a risk adjustment factor of about 0.424 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.297 to 0.502 depending on the payment segment). A more severe related category (HCC 135 and HCC 136) supersedes it when both are reported. See the full factor table on the HCC 137 category page.